Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 19/20 | 0.60 |
| ▸ | CCNE2 | O96020 | 4/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.44 |
| ▸ | CDK2 | P24941 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1269232 | 1.00 | IGF1R (0.60) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1269841 | 0.92 | IGF1R (0.71) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL4004129 | 0.90 | IGF1R (0.60) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1269636 | 0.90 | IGF1R (0.60) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1269805 | 0.89 | IGF1R (0.58) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1268519 | 0.89 | IGF1R (0.58) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1270129 | 0.88 | IGF1R (0.50) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL4007062 | 0.87 | IGF1R (0.60) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1269612 | 0.87 | IGF1R (0.60) | IGF1RCCNE2CCNE1CDK2 | |
| SCHEMBL1269849 | 0.86 | IGF1R (0.62) | IGF1RCCNE2CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2041138-A2 | PYRROLOTRIAZINE KINASE INHIBITORS | Brystol-Myers Squibb Company (US) | 2009-04-01 | — | — | EP | claimed |
| WO-2008005956-A2 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-01-10 | — | — | WO | claimed |
| EP-2041138-A2 | PYRROLOTRIAZINE KINASE INHIBITORS | Brystol-Myers Squibb Company (US) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008005956-A2 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-01-10 | — | — | WO | disclosed |